Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Business Leads World | 2022 | Series B | $14.3M | Beijing |
| X-EPIC | 2022 | Series B | Undisclosed | Nanjing |
| Bishi Technology | 2022 | Series C | $27.7M | Beijing |
| RVBUST | 2022 | Series A | Undisclosed | Shenzhen |
| GalaxySpace | 2022 | Series D | Undisclosed | Beijing |
| Biointron | 2022 | Series B | $72.6M | Shanghai |
| Baiying Bio | 2022 | Series B | $72.6M | Beijing |
| Intellective Bio | 2022 | Series C | $74.1M | Suzhou |
| Qdama | 2022 | Series D | Undisclosed | Guangzhou |
| Helixon | 2022 | Series A | $74.6M | Beijing |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 76 | Business Leads World | Series B | $14.3M | Beijing, China |
| 77 | X-EPIC | Series B | Undisclosed | Nanjing, China |
| 78 | Bishi Technology | Series C | $27.7M | Beijing, China |
| 79 | RVBUST | Series A | Undisclosed | Shenzhen, China |
| 80 | GalaxySpace | Series D | Undisclosed | Beijing, China |
| 81 | Biointron | Series B | $72.6M | Shanghai, China |
| 82 | Baiying Bio | Series B | $72.6M | Beijing, China |
| 83 | Intellective Bio | Series C | $74.1M | Suzhou, China |
| 84 | Qdama | Series D | Undisclosed | Guangzhou, China |
| 85 | Helixon | Series A | $74.6M | Beijing, China |
The Business Leads World proudly partners with direct lenders and business loan brokers.
X-EPIC is a Nanjing city-based startup aimed at building up China’s own EDA (Electronic Design Automation) industrial software technology.
Bishi Technology is committed to building the world's leading AI operation and maintenance engine.
RVBUST is a technology company that provides research and development of robot motion planning technology products.
GalaxySpace is a manufacturer of micro-satellites.
Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents.
Baiying Bio is a research and development outsourcing service provider.
Intellective Bio is a CDMO focusing on biopharmaceutical process development and large-scale production.
Qdama is a fresh agricultural product service provider that focuses on the operation of the fresh meat market.
Helixon is a biotechnology company that accelerates novel drug discovery for unmet medical needs.
Style3D is a software and service ecosystem for all fashion that enables designers and businesses to work on real-time 3D simulation.
Guanmai Technology is a leading SaaS company in the B2B field of fresh food in China.
AUTHINE offers low-code products that meet the digital upgrade needs of various enterprise sizes while also promoting business development.
ToDesk is an internet firm committed to integrating network technology and related technologies into remote, virtual, and cloud desktops.
Innovusion is an autonomous vehicle LiDAR technology developer.
Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.
Abogen Biosciences is a clinical stage biotechnology company focuses on developing nucleic acid-based RNA therapeutics.
Genki Forest is a beverage company with Internet genes which specializes in making sugar-free and low-calorie products.
XTransfer is a financial and risk control service company for foreign trade enterprises.
MingMed is a Chinese cancer therapy and vision care firm.
UncleQ is a food and beverage brand that focuses on fresh and healthy tea mainly fresh lemon tea with different special tea bases.
SmartX is a leading vendor of hyper-converged infrastructure and distributed storage products.
AIpark is provides a smart parking management solution.
OPay is a company that enables users to accomplish more with their money by providing smart financial services.
Quadtalent Technology is a provider of digital transformation and enterprise AI solutions.
Gaorong Capital has invested in 171 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Gaorong Capital's top investment sectors include Biotechnology, Medical, Software, Food and Beverage, Health Care. The firm invests across 50 different industry categories.
Among tracked funding rounds, OPay received $400.0M in a Series C round. Gaorong Capital's total known invested capital is $7.3B.
Gaorong Capital's average investment size is $68.0M across its portfolio of 171 companies.
Recent Gaorong Capital portfolio additions include Business Leads World, X-EPIC, Bishi Technology, RVBUST, GalaxySpace. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors